Palatin Technologies PTN
NASDAQ PTN
$12.02 -0.31 (-2.51%)
At close: Sep 10, 2026 · 4:00 PM EDT

Palatin Technologies (PTN) Total Liabilities (2011 - 2026)

Palatin Technologies' (PTN) quarterly Total Liabilities came in at $2.6 million in Q1 2026, down 73.97% on a YoY basis from $10.1 million in Q1 2025, and down 59.25% quarter-over-quarter from $6.5 million in Q4 2025.

Analysis

Palatin Technologies (PTN) Total Liabilities (2011 - 2026) Analysis & Trends

Palatin Technologies (PTN) has reported Total Liabilities for 16 consecutive years, with $2.6 million the latest figure, recorded in Q1 2026.

  • For the quarter ending Q1 2026, Total Liabilities fell 73.97% year-over-year to $2.6 million; the trailing twelve-month figure through Mar 2026 stood at $2.6 million (down 73.97% YoY), and the FY2025 full-year result was $8.0 million, down 25.89% from the prior year.
  • Total Liabilities eased to $2.6 million in Q1 2026 per PTN's latest filing, from $6.5 million in the prior quarter.
  • Across five years, Total Liabilities topped out at $24.5 million in Q4 2023 and bottomed at $2.6 million in Q1 2026.
  • Historically, Total Liabilities has averaged $13.2 million across 5 years, with a median of $11.1 million in 2024.
  • The sharpest annual moves came in 2023 and 2026: Total Liabilities jumped 56.82% in 2023, then plunged 73.97% in 2026.
  • Over 5 years, Total Liabilities stood at $15.6 million in 2022, then surged by 56.82% to $24.5 million in 2023, then tumbled by 56.39% to $10.7 million in 2024, then plunged by 39.56% to $6.5 million in 2025, then plunged by 59.25% to $2.6 million in 2026.
  • According to Business Quant data, Total Liabilities over the past three periods registered $2.6 million, $6.5 million, and $8.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Liabilities (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn 83.95 Bn
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn 37.53 Bn
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn 7.18 Bn
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn 10.02 Bn
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn 1.62 Bn
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn 4.20 Bn
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn 4.20 Bn
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn 13.24 Bn
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn 384.62 Mn
10 Palatin Technologies 46.98 Mn 46.98 Mn - 2.63 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 2.63 Mn
Dec 31, 2025 6.46 Mn
Sep 30, 2025 8.22 Mn
Jun 30, 2025 8.04 Mn
Mar 31, 2025 10.12 Mn
Dec 31, 2024 10.69 Mn
Sep 30, 2024 11.10 Mn
Jun 30, 2024 10.85 Mn
Mar 31, 2024 9.83 Mn
Dec 31, 2023 24.52 Mn
Sep 30, 2023 16.14 Mn
Jun 30, 2023 19.66 Mn
Mar 31, 2023 16.02 Mn
Dec 31, 2022 15.63 Mn
Sep 30, 2022 19.19 Mn
Jun 30, 2022 19.80 Mn
Mar 31, 2022 15.73 Mn
Dec 31, 2021 17.80 Mn
Sep 30, 2021 16.76 Mn
Jun 30, 2021 17.65 Mn